Tsukasa Ikarashi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
When the therapeutic drug l-DOPA, which is used to treat Parkinson's disease, is combined with magnesium oxide (MgO), a formulation change produces a dark substance. Infrared spectroscopy reveals that this substance is melanin. After allowing the l-DOPA and MgO mixture to stand, the l-DOPA content decreases significantly, and a new degradation product (the(More)
  • 1